Mutations in mtDNA: Are we scraping the bottom of the barrel?

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


The small, maternally inherited mtDNA has turned out to be a Pandora's box of pathogenic mutations: 12 years into the era of 'mitochondrial medicine,' about 100 pathogenic point mutations and innumerable rearrangements have been associated with a bewildering variety of multisystemic as well as tissue-specific human diseases. After reviewing the principles of mitochondrial genetics, we compare and contrast the clinical and pathological features of disorders due to mutations in genes affecting mitochondrial protein synthesis with those of mutations in protein-coding genes. In contrast to the striking progress in our understanding of etiology, pathogenesis is only partially explained by the rules of mitochondrial genetics and remains largely terra incognita. We review recent progress in prenatal diagnosis and epidemiology. Therapy is still woefully inadequate, but a number of promising approaches are being developed.




DiMauro, S., & Andreu, A. L. (2000). Mutations in mtDNA: Are we scraping the bottom of the barrel? In Brain Pathology (Vol. 10, pp. 431–441). International Society of Neuropathology.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free